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Abstract
Background: The risk-related behaviours and practices associated with injection drug use remain a driver of HIV and
hepatitis C virus (HCV) transmission throughout the world. Here we evaluated HIV and HCV transmission patterns in the
context of social networks of injection drug users (IDU) recruited from a higher incidence region in order to better
understand factors that contribute to ongoing transmission among IDU.
Methods: IDU recruited through a chain-referral method provided biological specimens for analysis. HIV and HCV positive
specimens were sequenced and analyzed using phylogenetic methods (Neighbour-joining and Bayesian) and transmission
patterns of HIV and HCV evaluated in the context of the recruitment networks.
Results: Among the 407 recruited IDU, HCV and HIV prevalence were 60.6% and 10.1%, respectively; 98% of HIV positive
individuals were co-infected with HCV. Thirty-six percent of HCV sequences were associated with clusters, compared to 67%
of HIV sequences. Four (16.7%) of the 24 HCV clusters contained membership separated by 2 or fewer recruitment cycles,
compared to 10 (41.6%) derived from more than one recruitment component. Two (28.6%) of the 7 HIV clusters contained
membership separated by 2 or fewer recruitment cycles while 6 (85.7%) were composed of inter component membership.
Conclusions: Few HIV and HCV transmissions coincided with the recruitment networks, suggesting that they occurred in a
different social context or a context not captured by the recruitment network. However, among the complete cohort, a
higher degree of HIV clustering indicates many are recent infections originating from within current social networks,
whereas a larger proportion of HCV infections may have occurred earlier in injecting history and in the context of a different
social environment.
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Introduction
The risk-related behaviours and practices associated with
injection drug use contribute to large numbers of infections with
blood-borne pathogens [1,2,3]. In Canada, these practices are the
largest contributor to new cases of hepatitis C virus (HCV)
infections, as well as a significant contributor to the Canadian HIV
epidemic, particularly among women [4]. Risk behaviors associ-
ated with injection drug use account for 17% of all new HIV
infections and 70–80% of new HCV cases in Canada [5]. While
national annual HCV incidence rates had declined to a nadir of
1.6 per 100,000 in 2006, more recent figures suggest a reversal in
this trend with an incidence estimate of 2.2 per 100,000 in 2008.
In 2005, Millson and colleagues [6] found that although HIV
incidence among injection drug users (IDU) in the province of
Ontario had remained relatively stable at 0.23 per 100 person
years, the incidence within the city of Ottawa, Canada was 25
times higher at 5.8 per 100 person years. Knowledge of the
distribution of these pathogens and of the social network
interactions between IDU can combine to provide a better
understanding of the dynamics of HIV and HCV transmission
within this at risk population.
Located within the National Capital Region of Canada, the City
of Ottawa consists of communities (neighbourhoods, suburbs,
villages and rural areas) separated by both physical (distance, rivers,
green space,highways) and demographic (language, socioeconomic,
ethnicity/race) barriers. The most recent estimates (2002) suggest
the number of people in Ottawa who inject drugs is 3,300, which
equates to about 4 IDU per 1,000 general population [3]. Within
the metropolitan area, IDUs tend to be concentrated in central core
areas where health and prevention services have been made more
readily available, although IDU populations are also present
throughout the region with poorly characterized linkages to the
central group and where access to services may be more limited.
In this study, members of IDU social networks in Ottawa were
recruited using a chain referral method in order to identify and
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and/or HCV infection. Since the intention is for the peers to be
recruited from a study participant’s personal social network, the
recruitment chains represent social linkages that exist within the
study population [7]. The method has proven to be effective at
recruiting from populations that are hard to reach or small relative
to the general population, and improving the chance of recruiting
a more representative sample of the more marginalized, least
accessible IDU who are farther removed from health and
prevention services [8]. Biological specimens in the form of dried
blood spots (DBS) were collected from all participants for
serological HIV and HCV testing. For positive specimens, viral
sequencing and phylogenetic analysis was used to establish the
presence or absence of transmission linkages within the network.
The purpose of this study was to document the impact of IDU
social network structure on viral transmission dynamics so as to
direct the development of prevention programs addressing
individual risk practices and behaviours.
Materials and Methods
Recruitment of study participants
IDU from Ottawa, Ontario, Canada were recruited by their
peers using a chain-referral method. Seven IDU ‘seeds’ who were
selected by recruiters after participating in previous studies were
recruited initially. In order to limit bias from highly networked
individual, each was asked to recruit only three of their IDU
contacts through the use of uniquely coded referral cards. Upon
presenting for interview, each new recruit was also asked to refer
three others in a similar fashion and so on, to a target enrolment of
400 participants. Research personnel kept track of who recruited
who throughout the duration of the study. Potential participants
were deemed eligible to participate in the study if they met all of
the following criteria:
N Possession of a study recruitment card;
N Capable of providing informed consent;
N Injected drugs in the previous six months; and,
N Had not already participated in this study.
Participants completed a structured personal interview and
provided a biological (DBS) specimen. The two part study
instrument first collected demographic information including data
on behaviours and practices documented to be associated with
HIV and HCV infection, followed by questions addressing the
investigation of the social and risk networks of IDUs based on
standard egocentric methods of network analysis. All data and
specimens were anonymous. All components of the study were
approved by the Ottawa Hospital Research Ethics Board and
reviewed and renewed on an annual basis. Subjects were informed
of the purpose of the study and provided separate signed consent
for the interview and for HIV and HCV blood tests.
Recruitment network diagrams were prepared using PAJEK
software [9].
Collection and storage of biological specimens
Dried blood spots (DBS) were collected onto 903 filter paper
cards (Whatman, USA) by the standard finger prick method using
a self-retracting lancet (Beckton-Dickinson, Canada). After satu-
rating each of five printed circles, DBS were air dried for 3 hours
(or over a weekend when collected on a Friday) at ambient
temperature and humidity, and then stored in a vacuum desiccator
at ambient temperature until weekly transport to the laboratory.
DBS were placed in gas-impermeable zipper lock (Bitran Saranex)
storage bags containing desiccant pouches for shipping and
storage. At the laboratory, the desiccated DBS were stored at
280 C until testing was performed.
Serological assays
DBS samples (J inch hole punch or equivalent) were screened
for HIV using the Genetic Systems rLAV HIV-1 EIA (BioRad,
Canada). Reactive samples having a signal to cutoff (sco) between
1.0–3.99 were repeated in duplicate. If both repeat wells were
negative (sco,1.0), the sample was reported as negative. If either
well was reactive (sco$1.0) the sample went on to confirmatory
testing using the Genetic Systems HIV-1 Western Blot (BioRad,
Canada). Screened samples with sco$4.0 went directly to Western
Blot. Both of these assays are approved for use with DBS samples.
All DBS samples were also screened for HCV by eluting one J0
DBS punch into the Genetic Systems rLAV HIV-1 EIA diluent
according to manufacturer’s instructions and testing the eluates
using the Ortho HCV Version 3.0 ELISA (Ortho-Clinical
Diagnostics, Canada). Highly reactive samples (sco.2.0) were
considered positive, low reactive samples (sco,2.0) were repeated
in duplicate. Samples were considered reactive if either of the
duplicates was reactive (sco.1.0). No confirmatory HCV assay
was available at the time of testing.
All of the HIV and HCV serological assays used, including
modification of the HCV assay, were validated in our laboratories
for use with DBS.
Molecular analysis
Isolation of Nucleic Acids from DBS. Nucleic acids were
isolated from all HIV and/or HCV positive specimens for
molecular analysis. Individual DBS were cut into 3–4 strips onto
a clean sterile surface using sterile disposable Littauer suture
scissors (Benlan Inc, Oakville, Canada). After eluting nucleic acids
from DBS into 3 ml EasyMag Lysis buffer (buffered guanidium
thiocyanate, BioMerieux Canada) for 1 hour at ambient
temperature, viral nucleic acids were isolated from DBS eluates
using the Nuclisens EasyMag system and reagents according to the
manufacturer’s instructions. Briefly, DBS eluates were transferred
to EasyMag cassettes, magnetic silica added, and silica-bound
nucleic acids washed to remove contaminants. In the final cycle,
nucleic acids were eluted into a low-salt buffer [10].
Amplification & Sequencing. HIV and HCV genetic regions
(2each) wereamplified from 10 ml nucleic acid extract using in house
nested reverse transcriptase PCR (RT-PCR) methods. The HIV-1
primers and method used were designed to target all HIV-1 group M
subtypes and are routinely used to determine strain and drug
resistance in Canada. The method targets HIV pol, producing
overlapping segments that span protease and the first 900 nucleotides
of reverse transcriptase (RT). The method and primer sequences are
available elsewhere [11]. The same protocol was used for HCV with
primers that were developed to detect most genotypes found in
Canada and have been used in several studies, but they have not been
thoroughly validated against all genotypes. The HCV primers
targeted portions of core (,460nucleotides, 59UTR.out.for:
TGATAGGGTGCTTGCGAGTG; Core_A.out.rev: GAGAGC-
AGGGCCARIARGAAGATAGA; 59UTR.in.for: GAGGTCTCG-
TAGACCGTGCA; Core.in.rev: GAGCAACCIGGIARRTTC-
CCTGTTG) and NS5B (550 nucleotides, NS5B-out.for: GTSTG-
GIARGACYTICTGGAAGAC; NS5B-out.rev: RGIGCRGART-
ACCTRGTCATAGCCT; NS5B-in.for: IACYATCATGGCIAA-
RARYGAGGT; NS5B-in.rev: ACCTRGTCATAGCCTCCGTG-
AA). Amplified templates were sequenced in both the 59 and 39
orientations using an ABI Prism 3130xl genetic analyzer. Sequences
were generated by aligning electropherograms to a reference
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Population-based (bulk) sequencing is the standard method used in
the majority of molecular epidemiology studies of HIV and HCV. In
the case of IDU, who are at higher risk of superinfection with HCV
[12] and probably HIV, it is possible that superinfections may occur.
Although the method used will miss clustering associated with minor
superinfecting variants this will not detract from associations
identified due to the majority species.
Phylogenetic Analysis. Sequences were aligned using
Clustalx software [13]. Phylogenetic trees were generated using
the neighbour-joining method of Saitou and Nei with the Kimura
2-Parameter model and pairwise deletion of gaps, as implemented
in the MEGA 4.0 [14] software package. The reliability of the
branching orders was assessed by bootstrap re-sampling (100
replicates). Cluster bootstrap values above 80% were considered
significant. Subtype/genotype reference sequences were obtained
from the HIV and HCV Sequence Databases (www.hiv.lanl.gov
and www.hcv.lanl.gov).
Results
Study participants and networks
Four hundred and seven (407) IDU were recruited between
September and December, 2007. All participants completed the
interview process and only one refused to provide a DBS specimen.
As described in Table 1, the seven seeds generated four
individual recruitment networks consisting of 12, 13, 126 and 253
members resulting from 4, 4, 15 and 22 recruitment rounds (chain
lengths), respectively. Three seeds recruited no additional
participants. The two largest networks represented 93% of the
overall sample. Figure 1 is a schematic of the second largest
recruitment network, showing recruitment rounds and relation-
ships between HIV and HCV infections. The majority (80%) of
the participants were male. The complete demographic data is
presented as part of a separate manuscript.
Serology
Of the 406 DBS specimens collected, 41 (10.1%) were confirmed
anti-HIV-1 antibody positive and 246 (60.6%), anti-HCV antibody
positive. All but one of the HIV positive specimens were also HCV
positive, such that overall, 9.9% of the cohort was HIV/HCV
coinfected.Amongthose HIVorHCVinfected,the coinfectionrate
was 97.6% and 16.3%, respectively. One hundred and fifty nine
(39.2%) specimens were negative for both HIV and HCV.
Molecular Analysis of HIV and HCV
HCV genotyping / HIV subtyping. Only specimens that
were HCV and/or HIV positive by serology were followed up
with molecular analysis. Of these, we were able to generate
sequences from at least one of the two genetic regions targeted for
each virus from 74% (183/246) and 71% (29/41) of HCV and
HIV positive specimens, respectively. In the case of HCV, the core
and NS5B genetic regions generated 175 (71.1%) and 164 (66.7%)
nucleotide sequences, respectively. In the case of two HIV positive
specimens, only sequence from the RT genetic region was
available.
HCV genotypes and HIV subtypes were determined by
phylogenetic analysis performed with the inclusion of reference
sequences. HCV genotypes (Table 2) were found to be
predominantly 1a (64.5%) and 3a (21.9%). HCV genotypes for
which sequence data was available from both genetic regions were
in agreement for 152 of the 156 (97.4%) specimens. Three of the
four discordant specimens were genotype 1a in core and 3a in
NS5B, with the fourth being 3a in core and 2b in NS5B, possibly
indicative of HCV superinfection.
As with HCV, the HIV subtypes were also determined using
phylogenetic methods. Ninety percent (90%) of the HIV positive
specimens were subtype B, with the remaining 10% subtype C.
Subtypes were determined from pol (protease and RT) sequences
except in the case of the two specimens for which only RT
sequences were available.
Nucleotide sequences have been deposited in GenBank under
the following accession numbers: HIV pol: JF817355–JF817383;
HCV core: JF824151–JF824251 and JF824253–JF824326; HCV
NS5B: JF824327–JF824490.
Clusters. Separate phylogenetic analysis of 176 core and 166
NS5B sequences revealed that 58 (32%) of the HCV specimens
with amplifiable RNA were related to at least one other HCV
infection within the recruitment networks. In all, 24 HCV
infection clusters were identified in at least one of the two
regions analyzed, with cluster size ranging from 2 to 7 participants
[Figure 2A and Table 3]. Similar phylogenetic analysis of HIV
sequences revealed that 18 (62%) of the 29 specimens for which
HIV sequence data was obtained fell within 7 distinct transmission
clusters ranging in size from 2 to 4 participants (Figure 2B). Of the
24 HCV clusters, only 4 (16.7%) contained membership separated
by 2 or fewer recruitment cycles, in contrast to 10 (41.6%) clusters
that were derived from more than one recruitment component.
Two (28.6%) of the 7 unique HIV clusters, contained membership
separated by 2 or fewer recruitment cycles while 6 clusters (85.7%)
were composed of inter component membership.
Among the 13 coinfected participants that were found to be HIV
cluster members and where HCV sequence results were also
available, 8 (61.5%) also demonstrated HCV clustering, including
two cases of concordant clustering in which pairs of participants
shared phylogenetically related HIV and HCV infections. Discor-
dant clustering was observed in two cases of coinfection where the
coinfecting viruses each clustered with separate members of the
network. Conversely, of the 5 coinfected participants where HIV
sequences were shown not to cluster and for which HCV sequence
data was available, only 1 (20%) demonstrated clustering with an
HCV infection of another network participant. Unfortunately in
this case, although the related HCV infected partner was also HIV
co-infected, we were unable to generate HIV sequence data thus
pre-empting further cluster analysis.
Discussion
Veiled risk behaviors and the marginalization of populations
present unique challenges for understanding viral transmission
dynamics within social networks of IDU. Here we have applied
molecular phylogenetic analysis of HIV and HCV of infected
participants collected through chain-referral sampling of Ottawa’s
IDU population, in an attempt to understand the impact of social
network structure on the transmission of these viruses. The
generation of unique genetic variants due to elevated replication
rates and error prone reverse transcription allows genetic
concordance to serve as a surrogate of epidemiologic linkages in
the study of HIV and HCV transmission [15,16,17]. It is
important to note that using these methods, it is not possible to
determine the direction of transmission, or even if the virus was
transmitted directly between contacts [18]. Rather we use
phylogenetic clustering as an indicator of viral movement within
the study populations in order to gauge the effect of social network
structure on transmission dynamics.
By way of sampling hard-to-reach populations, chain-referral
sampling methods, when coupled with phylogenetics should allow
Transmission Patterns of HIV and HCV among IDU
PLoS ONE | www.plosone.org 3 July 2011 | Volume 6 | Issue 7 | e22245Figure 1. Recruitment network #2. Both A and B represent the same network of 126 participants. Red circles in A indicate HCV positive and
orange circles in B indicate HIV positive participants. Coloured boxes indicate phylogenetically related infections within the network. Green frames
indicate phylogenetic link(s) to other network(s) with (coloured) or without (white) links within the network. All branches have a length of 1. Vertical
scale indicates recruitment rounds (distance) from seed.
doi:10.1371/journal.pone.0022245.g001
Table 1. Characteristics of recruitment networks.
Network
Component Seed Gender Size (n=)
Recruitment
rounds Male Female
HCV
positive
HIV
positive
1 M 253 22 210 83.0% 43 17.0% 61% 9%
2 M 126 15 99 78.6% 27 21.4% 60% 14%
3 F 13 4 8 61.5% 5 38.5% 23% 0%
4 F 12 4 5 41.7% 7 58.3% 92% 0%
5 M 1 0 1 100.0% 0 0.0% 100% 0%
6 M 1 0 1 100.0% 0 0.0% 100% 0%
7 F 1 0 0 0.0% 1 100.0% 0% 0%
Total 407 324 79.6% 83 20.4% 60.6% 10.1%
doi:10.1371/journal.pone.0022245.t001
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populations. It would seem reasonable that virus transmissions
would occur more frequently between social contacts within a
smaller network space (fewer recruitment steps between partici-
pants) than between those more distally related within a network
or belonging to another network component altogether.
Perhaps the most surprising finding of this study is that viral
transmission events do not appear to be occurring along the
recruitment lineages of the network (dyads) or even within the
immediate recruitment network space. For the purpose of this
discussion, we define a transmission dyad as any two recruitment
network direct contacts identified through the chain-referral
sampling who are both infected with a phylogenetically related
virus. Collectively, we have identified seven unique HIV
phylogenetic clusters indicative of either indirect or direct intra/
inter component transmissions. However, a common virus is never
identified in any of the occasions where an HIV-positive
participant recruits another HIV-positive contact, and only occurs
in three instances for HCV infections. For the two occasions where
two individuals share a related HIV infection and a common
recruitment network contact (either uninfected or infected with a
phylogenetically unrelated virus), the HIV cluster includes HIV
positive participants recruited from within different components.
Likewise only 10.3% of HCV phylogenetic clustering appears to
have resulted from recruitment; in other words, an HCV-positive
individual recruiting a contact infected with a phylogenetically
related virus. In their study of 199 IDU, Aitken and colleagues
found more of HCV clustering (18%) was due to social dyads, but
one key difference between our studies is that the Aitken study only
recruited partners with whom participants had injected in the
previous 6 months [19]. In addition, through the use of named
injecting ‘partners’, they found 577 dyadic relationships between
participants, whereas we were limited to the 400 dyadic
recruitment relationships from our 4 recruitment networks.
T h eq u e s t i o nt h e nb e c o m e s ,w h a tf a c t o r sh a v er e s u l t e di n
such small numbers of transmission dyads being observed within
the recruitment networks. It is important to note that the data
presented in this paper represents only a snapshot in time of the
social network structure of people in Ottawa who inject drugs
and does not adequately describe the many possible (and
probable) past and present social interactions between the
recruited individuals. Two individuals who are only distally
Table 2. HCV genotype distribution.
Genotype n= %
1a 120 65.9
1b 9 4.9
2a 3 1.6
2b 9 4.9
3a 41 22.5
Total 182 100.0
doi:10.1371/journal.pone.0022245.t002
Figure 2. Phylogenetic analysis. A. Neighbour Joining analysis of all HIV-1 pol sequences generated. B. Analysis of all clustered HCV core
sequences. In each tree, bootstrap values greater than 80% are indicated. In situations where HCV clusters based on core analysis (5, 9 & 20) fell below
the 80% bootstrap cut off, similar analysis of NS5B (not shown) resolved clusters with bootstrap values above 80%.
doi:10.1371/journal.pone.0022245.g002
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within separate components at the time of recruitment may in
fact be more closely related within the social network or may
even currently exist as occult social contacts not captured as part
of the recruitment process. Social interactions (links) between
participants appearing distally related within the current
recruitment network may be borne out by social network
analysis based on questionnaire responses that will evaluate how
closely any two individuals are truly related in the IDU social
framework.
A limitation of this study is the potential bias of the sampling
methodology. Targeting a difficult to reach population (IDU) can
come at the expense of randomness. As such, additional analysis
would be required in order to develop prevalence estimates of
HIV/HCV for the IDU community as a whole. Future analysis
will include an assessment of sampling bias and the effectiveness of
the sampling methodology in reaching hidden populations.
As the majority of HIV and HCV positive individuals in this
study reported prior knowledge of their infection status it is
conceivable that a positive viral diagnosis coupled with public
health-directed counseling has resulted in behavioral changes
leading to social network restructuring. For example, information
pertaining to safer injecting practices may have resulted in both
the dissolution of an existing networked transmission dyad and the
prevention of onward transmission thus limiting the formation of
additional dyads with new social contacts. An understanding of
how long recruitment network participants (infected or not) knew
each other might shed light on how the durability of network
connections influences transmission patterns.
This said, it is also possible that network structure may be more
or less stable and that clustering in the absence of transmission
dyad formation may be an indication of hidden epidemic drivers.
It is possible that the recruitment process utilized did not
sufficiently sample from the most marginalized portions of the
IDU network, which by default would also be those with the least
access to public health interventions. It may be the hidden portions
of the network that serve as transmission bridges between distal
portions of the larger components or between independent
components. Intuitively, we would likely have seen the imprinting
of network recruitment on phylogenetic clustering if HIV or HCV
outbreaks were occurring within portions of the visible network.
In the case of HCV, with an overall network prevalence of
60.6%, it may also be difficult for the determinants of transmission
dyad formation (risk behavior and serodiscordance among current
social network contacts) to occur simultaneously. While the
likelihood of contact with an HCV-positive individual is elevated,
the most susceptible IDU (most at risk by behavior) would have
been exposed and infected very early in their injecting history
[20,21] thus preventing the formation of a transmission dyad, and
leading to the relatively low level (38%) of HCV phylogenetic
clustering observed in the study. Possibly the herd immunity effect
imposed by prevalent HCV infections coupled with effective
public health interventions tied to HIV prevention, disrupts the
transmission chains within the visible network, although transmis-
sions may continue to flow along undetected and otherwise
unsampled portions of the IDU network.
While the HCV infections detected may have occurred earlier
in participants’ injecting histories, and in the context of a different
social network structure, the opposite may be true for HIV
infections. Although the prevalence of HIV remains low at 10.1%,
a large percentage of these infections formed clusters within the
recruitment networks (62.1%), suggesting that many of the HIV
infections are more recent, with their origin residing in the context
of the current social network.
This study demonstrates that the complementary use of social
network analysis and molecular epidemiological methods can be
effective in describing the transmission dynamics of blood-borne
pathogensamongpersonswhoinjectdrugs,informationthatisessential
to targeted prevention strategies and sound public health policy.
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Table 3. Composition of Phylogenetic Clusters and links
within and between Network Components.
Virus Cluster Size
Intra Component Links
Degrees of Separation***
Inter Component
Link(s)
HCV 1 3 0, 8, 9
22 3
32 Y E S
42 2
5 7 2, 9, 11, 12, 20 YES
62 Y E S
72 Y E S
82 1 5
93 0 Y E S
10 3 2 YES
11 2 5
12 3 8 YES
13 2 YES
14 2 YES
15 2 0
16 2 6
17 2 3
18 2 8
19 2 1
20 2 16
21 2 2
22 2 YES
23 3 11, 14, 14
24 2 4
HIV 1 2 11
22 Y E S
3 4 1, 20 YES
43 1 Y E S
52 Y E S
62 Y E S
73 9 Y E S
***number of recruitment cycles separating clustered specimens.
doi:10.1371/journal.pone.0022245.t003
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